ifosfamide has been researched along with trofosfamide in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (48.57) | 18.7374 |
| 1990's | 6 (17.14) | 18.2507 |
| 2000's | 10 (28.57) | 29.6817 |
| 2010's | 2 (5.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burckhardt, G; Flörl, S; Hagos, Y; Kühne, A; Marada, VV | 1 |
| Brock, N; Pohl, J; Stekar, J | 2 |
| Vogel, E | 1 |
| Ellenberger, J; Mohn, GR | 1 |
| Beijnen, JH; Bult, A; de Kraker, J; Kaijser, GP; Underberg, WJ; Wiese, G | 1 |
| Brock, N; Pohl, J; Schneider, B | 1 |
| Brock, N | 3 |
| Masurel, D; Wainer, IW | 1 |
| De Dominicis, G; De Marinis, E; Della Morte, R; Quinto, I; Staiano, N | 1 |
| Belisario, MA; Della Morte, R; Mugnoz, B; Remondelli, P; Staiano, N | 1 |
| Budzyński, W; Kinas, R; Kuśnierczyk, H; Misiura, K; Paprocka, M; Radzikowski, C; Rak, J; Stec, W | 1 |
| Franz, G; Lietz, H | 1 |
| Breuel, HP; Burkert, H; Lücker, PW; Wetzelsberger, N | 1 |
| Adolphe, M; Deysson, G; Semont, H | 1 |
| Adolphe, M; Deysson, G; Hecquet, C; Semont, H | 2 |
| Harbers, E; Lindemann, H | 1 |
| Schmid, SM; Struck, RF; Waud, WR | 1 |
| Blaschke, G; Boos, J; Jürgens, H; Küpker, F | 1 |
| Adler, ID; Ehling, UH; Favor, J; Neuhäuser-Klaus, A | 1 |
| Acampora, A; Biglietto, M; Malorni, A; Miraglia, N; Sannolo, N | 1 |
| Halme, M; Isokangas, OP; Joensuu, H; Mäntylä, M; Mattson, K; Pekonen, M; Pyrhönen, S; Ruotsalainen, T; Sarna, S | 1 |
| Brinker, A; Brüggemann, SK; Kisro, J; Letsch, C; Wagner, T | 1 |
| Finckenstein, FG; Graf, N; Gruhn, B; Hasan, C; Hero, B; Klingebiel, T; Koscielniak, E; Kremens, B; Laws, HJ; Niemeyer, C; Schulz, A; Selle, B; Wawer, A; Zintl, F | 1 |
| Baumann, F; Niederwieser, D; Niemeyer, U; Pönisch, W; Preiss, R; Stefanovic, D | 1 |
| Hartmann, JT; Kanz, L; Kopp, HG | 1 |
| Bechrakis, NE; Coupland, SE; Fischer, L; Jahnke, K; Korfel, A; Thiel, E; Wagner, T; Willerding, G | 1 |
| Bechrakis, NE; Coupland, SE; Jahnke, K; Komm, J; Korfel, A; Stein, H; Thiel, E | 1 |
| Beck, JD; Bielack, S; Bölling, T; Dörr, HG; Jürgens, H; Klingebiel, T; Koscielniak, E; Langer, T; Paulides, M; Sauer, R; Stöhr, W; Willich, N | 1 |
| Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J | 1 |
| Bechrakis, NE; Fischer, L; Jahnke, K; Korfel, A; Kraemer, DF; Thiel, E; Willerding, G | 1 |
| Deroussent, A; Giraud, B; Hebert, G; Paci, A; Vassal, G; Veal, GJ | 1 |
3 review(s) available for ifosfamide and trofosfamide
| Article | Year |
|---|---|
Genetic effects of cyclophosphamide, ifosfamide and trofosfamide.
Topics: Animals; Chromosomes; Cyclophosphamide; Drosophila melanogaster; Escherichia coli; Genes, Dominant; Genes, Lethal; Humans; Ifosfamide; Mice; Mutagens; Mutation; Nitrogen Mustard Compounds; Oxazines; Plants; Recombination, Genetic; Saccharomyces cerevisiae; Salmonella typhimurium; Serratia marcescens; Translocation, Genetic | 1976 |
Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial Award lecture.
Topics: Cyclophosphamide; Humans; Ifosfamide; Mesna; Organ Specificity | 1989 |
Oxazaphosphorines: new therapeutic strategies for an old class of drugs.
Topics: Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Cytochrome P-450 Enzyme System; Drug Delivery Systems; Drug Design; Genetic Therapy; Humans; Ifosfamide; Neoplasms | 2010 |
5 trial(s) available for ifosfamide and trofosfamide
| Article | Year |
|---|---|
[Results of the Hamburg ovarian blastoma study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Germany, West; Humans; Ifosfamide; Melphalan; Methotrexate; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Random Allocation; Tegafur; Vincristine | 1985 |
Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer--a feasibility study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Finland; Humans; Ifosfamide; Injections, Subcutaneous; Interferon-alpha; Isotretinoin; Lung Neoplasms; Male; Middle Aged | 2000 |
New insights into the clinical pharmacokinetics of trofosfamide.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Biological Availability; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Molecular Structure | 2002 |
Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cyclophosphamide; Eye Neoplasms; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Retinal Neoplasms; Retrospective Studies; Surveys and Questionnaires; Survival Rate; Vitreous Body | 2006 |
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine | 2008 |
27 other study(ies) available for ifosfamide and trofosfamide
| Article | Year |
|---|---|
Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Humans; Liver-Specific Organic Anion Transporter 1; Molecular Structure; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Peptides; Solute Carrier Organic Anion Transporter Family Member 1B3 | 2015 |
[Antidote against the urotoxic effects of the oxazaphorine derivatives cyclophosphamide, ifosfamide and trofosfamide].
Topics: Animals; Antidotes; Carcinosarcoma; Cyclophosphamide; Ifosfamide; Mercaptoethanol; Mesna; Phosphoramide Mustards; Rats; Urine | 1979 |
Mutagenic activity of cyclophosphamide, trofosfamide, and ifosfamide in drosophila melanogaster. specific induction of recessive lethals in the absence of detectable chromosome breakage.
Topics: Animals; Chromosome Aberrations; Cyclophosphamide; Dose-Response Relationship, Drug; Drosophila melanogaster; Genes, Dominant; Genes, Lethal; Genes, Recessive; Ifosfamide; Mutation; Nitrogen Mustard Compounds; Oxazines | 1975 |
Gas chromatographic determination of ifosfamide in microvolumes of urine and plasma.
Topics: Antineoplastic Agents; Child; Chromatography, Gas; Cyclophosphamide; Humans; Ifosfamide; Microchemistry | 1991 |
Basic principles in preclinical cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ifosfamide; Mechlorethamine; Mice; Neoplasms; Nitrogen Mustard Compounds; Rats | 1990 |
Analytical and preparative high-performance liquid chromatographic separation of the enantiomers of ifosfamide, cyclophosphamide and trofosfamide and their determination in plasma.
Topics: Antineoplastic Agents; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Cyclophosphamide; Humans; Ifosfamide; Stereoisomerism | 1989 |
Induction of sperm abnormalities in mice by ifosfamide and trofosfamide.
Topics: Animals; Cyclophosphamide; Epididymis; Ifosfamide; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Organ Size; Sperm Count; Spermatozoa; Testis | 1988 |
In vitro activation of isophosphamide and trophosphamide to metabolites mutagenic for bacteria.
Topics: Animals; Aroclors; Chlorodiphenyl (54% Chlorine); Cyclophosphamide; Drug Interactions; Ifosfamide; Liver; Male; Methylcholanthrene; Monoamine Oxidase Inhibitors; Mutagenicity Tests; Phenobarbital; Rats; Rats, Inbred Strains; Salmonella typhimurium | 1986 |
Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Ifosfamide; Lethal Dose 50; Leukemia, Experimental; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Plasmacytoma; Stereoisomerism | 1986 |
Ideas and reality in the development of cancer chemotherapeutic agents, with particular reference to oxazaphosphorine cytostatics.
Topics: Alkylating Agents; Antineoplastic Agents; Biotransformation; Cyclophosphamide; Female; Humans; Ifosfamide; Inactivation, Metabolic; Male; Nitrogen Mustard Compounds; Prostatic Neoplasms; Structure-Activity Relationship; Sulfhydryl Compounds | 1986 |
Bioavailability of orally administered mesna.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Biological Availability; Cyclophosphamide; Humans; Ifosfamide; Injections, Intravenous; Male; Mercaptoethanol; Mesna | 1984 |
[Comparative study of the antimitotic effects of cyclophosphamide, trofosfamide and ifosfamide on meristema plant cells and animal cells in in vitro culture].
Topics: Animals; Cells, Cultured; Cricetinae; Cyclophosphamide; Fibroblasts; Ifosfamide; Kidney; Mitosis; Plant Cells | 1981 |
The oxazaphosphorines.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Humans; Ifosfamide; Nitrogen Mustard Compounds; Structure-Activity Relationship | 1983 |
Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.
Topics: Animals; Cyclophosphamide; Cystitis; Female; Ifosfamide; Kidney; Mercaptoethanol; Mesna; Rats; Urinary Bladder | 1981 |
Effects of oxazaphosphorine cytostatics on granuloid progenitor cell (CFUc) proliferation in mice.
Topics: Alkylating Agents; Animals; Bone Marrow; Bone Marrow Cells; Colony-Forming Units Assay; Cyclophosphamide; Depression, Chemical; Granulocytes; Hematopoietic Stem Cells; Ifosfamide; Mice | 1982 |
[Interaction of the three alkylating drugs, cyclophosphamide, ifosfamide and trofosfamide, with DNA and DNA-constituents in vitro (author's transl)].
Topics: Alkylating Agents; Animals; Cyclophosphamide; Deoxyribonucleosides; DNA Replication; Female; Ifosfamide; Microsomes, Liver; Rats | 1980 |
Effect of three alkylating antimitotic agents and their metabolites on in vitro monogranulocytic colony forming cells from mouse bone marrow.
Topics: Alkylating Agents; Animals; Bone Marrow Cells; Cyclophosphamide; Granulocytes; Hematopoietic Stem Cells; Ifosfamide; Mice; Mitosis | 1981 |
Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Screening Assays, Antitumor; Humans; Ifosfamide; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Phosphoramide Mustards; Tumor Cells, Cultured | 1994 |
Trofosfamide metabolism in different species--ifosfamide is the predominant metabolite.
Topics: Animals; Antineoplastic Agents; Biotransformation; Chromatography, High Pressure Liquid; Cyclophosphamide; Female; Hydroxylation; Ifosfamide; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Oxidation-Reduction; Rabbits; Rats; Rats, Sprague-Dawley | 1993 |
Induction of specific-locus and dominant lethal mutations in male mice by ifosfamide (Holoxan).
Topics: Animals; Cyclophosphamide; Genes, Dominant; Genes, Lethal; Germ Cells; Ifosfamide; Male; Mice; Mice, Inbred Strains; Mutagens; Mutation; Spermatozoa | 1998 |
Determination of cyclophosphamide and ifosphamide in urine at trace levels by gas chromatography/tandem mass spectrometry.
Topics: Cyclophosphamide; Gas Chromatography-Mass Spectrometry; Humans; Ifosfamide; Monitoring, Physiologic; Occupational Exposure; Sensitivity and Specificity | 1999 |
High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Germany; Hematologic Diseases; Humans; Ifosfamide; Infant; Kidney Diseases; Kidney Neoplasms; Life Tables; Lung Neoplasms; Male; Melphalan; Peripheral Blood Stem Cell Transplantation; Prognosis; Stomatitis; Survival Analysis; Thiotepa; Transplantation, Autologous; Wilms Tumor | 2002 |
Investigations on the pharmacokinetics of trofosfamide and its metabolites-first report of 4-hydroxy-trofosfamide kinetics in humans.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Cyclophosphamide; Female; Humans; Ifosfamide; Lymphoproliferative Disorders; Male; Middle Aged | 2004 |
Hypersensitivity pneumonitis associated with the use of trofosfamide.
Topics: Administration, Oral; Aged; Alveolitis, Extrinsic Allergic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cystitis; Drug Administration Schedule; Female; Femur; Germany; Humans; Ifosfamide; Nausea; Neoplasm Metastasis; Nerve Sheath Neoplasms; Phosphoramide Mustards; Prednisolone; Pulmonary Fibrosis; Vomiting | 2004 |
Pharmacokinetics and efficacy of ifosfamide or trofosfamide in patients with intraocular lymphoma.
Topics: Aged; Antineoplastic Agents, Alkylating; Cyclophosphamide; Disease-Free Survival; Eye Neoplasms; Humans; Ifosfamide; Infusions, Intravenous; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prospective Studies; Salvage Therapy | 2005 |
Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dactinomycin; Female; Follow-Up Studies; Humans; Ifosfamide; Incidence; Male; Multivariate Analysis; Sarcoma; Thyroid Diseases; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Vincristine | 2007 |
Ifosfamide or trofosfamide in patients with intraocular lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Cyclophosphamide; Eye Neoplasms; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Middle Aged; Survival Analysis; Survivors; Time Factors; Vitrectomy | 2009 |